📰 Complement Therapeutics News
Page 2 - Complement Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Complement Therapeutics. Real-time updates on events, politics, business and more.
July 13, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
July 4, 2023
Here are six biotech spinouts across the globe that have received funding over the past year, that you should know about.
May 17, 2023
CTx was spun out of the University of Manchester in 2021
April 23, 2023
The biggest rounds of recent biotech financings are from startups raising money to advance their research to the clinic. Here’s a look back at funding rounds from companies such as Abdera Therapeutics, Complement Therapeutics, and Enveda Biosciences.
April 17, 2023
/PRNewswire/ -- Complement Therapeutics GmbH (CTx), a preclinical stage biotechnology company developing novel therapeutics for complement mediated diseases,...
April 17, 2023
Copyright BusinessAMBE 08.07 - Gimv invests in Complement Therapeutics Investment group participates in a EUR 72 million financing round of Complement Therapeutics to finance the further... | April 17, 2023
April 17, 2023
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
June 11, 2022
Press release content from Business Wire. The AP news staff was not involved in its creation.
June 11, 2022
CANbridge CAN106 Phase 1 Data Presented at the European Hematology Association 2022 Congress
June 11, 2022
Rapid and potent C5 inhibition achieved with complete and sustained blockage of complement by a single dose of CAN106 Data to be presented at the 14th International Conference on Complement